<DOC>
	<DOC>NCT00195338</DOC>
	<brief_summary>The purpose of the study is to determine the long term safety of Enbrel in adults with active rheumatoid arthritis in Luxemburg. This is a post-marketing surveillance study in rheumatology practice patients. All patients initiated with Enbrel will be observed from the start of the study in Feb 2003 for a period of at least 5 years.</brief_summary>
	<brief_title>Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Have moderate to severe active rheumatoid arthritis Be aged of 17 years or more Have inadequate response to DMards Give written informed consent Physician decides to prescribe Enbrel</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
</DOC>